These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 29922995

  • 1. In Vitro Study of Antitumor Effect of Antimicrobial Peptide Tachyplesin I in Combination with Cisplatin.
    Kuzmin DV, Emel'yanova AA, Kalashnikova MB, Panteleev PV, Ovchinnikova TV.
    Bull Exp Biol Med; 2018 Jun; 165(2):220-224. PubMed ID: 29922995
    [Abstract] [Full Text] [Related]

  • 2. Tachyplesin induces apoptosis in non-small cell lung cancer cells and enhances the chemosensitivity of A549/DDP cells to cisplatin by activating Fas and necroptosis pathway.
    Wu J, Chen X, Zhang J, Chen J, Wang Y, Wei T, Ma J, Li Y, Mo T, He Z, Zhang H.
    Chem Biol Drug Des; 2021 Apr; 97(4):809-820. PubMed ID: 33245189
    [Abstract] [Full Text] [Related]

  • 3. Structure-Activity and -Toxicity Relationships of the Antimicrobial Peptide Tachyplesin-1.
    Edwards IA, Elliott AG, Kavanagh AM, Blaskovich MAT, Cooper MA.
    ACS Infect Dis; 2017 Dec 08; 3(12):917-926. PubMed ID: 28960954
    [Abstract] [Full Text] [Related]

  • 4. Efflux of potassium ion is an important reason of HL-60 cells apoptosis induced by tachyplesin.
    Zhang HT, Wu J, Zhang HF, Zhu QF.
    Acta Pharmacol Sin; 2006 Oct 08; 27(10):1367-74. PubMed ID: 17007745
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of tachyplesin I injury to bacterial membranes and intracellular enzymes, determined by laser confocal scanning microscopy and flow cytometry.
    Hong J, Guan W, Jin G, Zhao H, Jiang X, Dai J.
    Microbiol Res; 2015 Jan 08; 170():69-77. PubMed ID: 25267486
    [Abstract] [Full Text] [Related]

  • 6. Effects of tachyplesin I on human U251 glioma stem cells.
    Ding H, Jin G, Zhang L, Dai J, Dang J, Han Y.
    Mol Med Rep; 2015 Apr 08; 11(4):2953-8. PubMed ID: 25434611
    [Abstract] [Full Text] [Related]

  • 7. Modified horseshoe crab peptides target and kill bacteria inside host cells.
    Amiss AS, von Pein JB, Webb JR, Condon ND, Harvey PJ, Phan MD, Schembri MA, Currie BJ, Sweet MJ, Craik DJ, Kapetanovic R, Henriques ST, Lawrence N.
    Cell Mol Life Sci; 2021 Dec 31; 79(1):38. PubMed ID: 34971427
    [Abstract] [Full Text] [Related]

  • 8. Characterization of Tachyplesin Peptides and Their Cyclized Analogues to Improve Antimicrobial and Anticancer Properties.
    Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ, Lawrence N, Troeira Henriques S.
    Int J Mol Sci; 2019 Aug 26; 20(17):. PubMed ID: 31455019
    [Abstract] [Full Text] [Related]

  • 9. D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line.
    Evans HG, Guthrie JW, Jujjavarapu M, Hendrickson N, Eitel A, Park Y, Garvey J, Newman R, Esckilsen D, Heyl DL.
    Protein Pept Lett; 2017 Aug 26; 24(7):590-598. PubMed ID: 28641565
    [Abstract] [Full Text] [Related]

  • 10. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
    Shi SL, Wang YY, Liang Y, Li QF.
    World J Gastroenterol; 2006 Mar 21; 12(11):1694-8. PubMed ID: 16586536
    [Abstract] [Full Text] [Related]

  • 11. Deletion of all cysteines in tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding.
    Ramamoorthy A, Thennarasu S, Tan A, Gottipati K, Sreekumar S, Heyl DL, An FY, Shelburne CE.
    Biochemistry; 2006 May 23; 45(20):6529-40. PubMed ID: 16700563
    [Abstract] [Full Text] [Related]

  • 12. Influences of disulfide connectivity on structure and antimicrobial activity of tachyplesin I.
    Shi J, So LY, Chen F, Liang J, Chow HY, Wong KY, Wan S, Jiang T, Yu R.
    J Pept Sci; 2018 Jun 23; 24(6):e3087. PubMed ID: 29870123
    [Abstract] [Full Text] [Related]

  • 13. Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms.
    Hong J, Hu J, Ke F.
    Antimicrob Agents Chemother; 2016 Oct 23; 60(10):6067-75. PubMed ID: 27480861
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O, Ghiselli R, Silvestri C, Kamysz W, Orlando F, Mocchegiani F, Di Matteo F, Riva A, Lukasiak J, Scalise G, Saba V, Giacometti A.
    Antimicrob Agents Chemother; 2007 Jun 23; 51(6):2005-10. PubMed ID: 17403995
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro study on cytotoxicity of recombinant β-hairpin peptides.
    Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Balandin SV, Serebrovskaya EO, Belogurova-Ovchinnikova OY, Ovchinnikova TV.
    Chem Biol Drug Des; 2018 Jan 23; 91(1):294-303. PubMed ID: 28815904
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro.
    Morimoto M, Mori H, Otake T, Ueba N, Kunita N, Niwa M, Murakami T, Iwanaga S.
    Chemotherapy; 1991 Jan 23; 37(3):206-11. PubMed ID: 1889308
    [Abstract] [Full Text] [Related]

  • 17. Tachyplesin activates the classic complement pathway to kill tumor cells.
    Chen J, Xu XM, Underhill CB, Yang S, Wang L, Chen Y, Hong S, Creswell K, Zhang L.
    Cancer Res; 2005 Jun 01; 65(11):4614-22. PubMed ID: 15930279
    [Abstract] [Full Text] [Related]

  • 18. Effect of N- and C-Terminal Modifications on Cytotoxic Properties of Antimicrobial Peptide Tachyplesin I.
    Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Ovchinnikova TV.
    Bull Exp Biol Med; 2017 Apr 01; 162(6):754-757. PubMed ID: 28429216
    [Abstract] [Full Text] [Related]

  • 19. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
    Cirioni O, Giacometti A, Kamysz W, Silvestri C, Riva A, Della Vittoria A, Abbruzzetti A, Lukasiak J, Scalise G.
    Peptides; 2007 Apr 01; 28(4):747-51. PubMed ID: 17331619
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
    Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, Cirioni O, Gabrielli E, Lenci I, Kamysz W, Kamysz E, Giacometti A, Scalise G, Barchiesi F, Offidani A.
    Peptides; 2009 Oct 01; 30(10):1794-7. PubMed ID: 19591887
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.